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Surgical Menopause Increases Salt Sensitivity
of Blood Pressure
Ivonne Hernandez Schulman, Pedro Aranda, Leopoldo Raij, Maddalena Veronesi,
Francisco J. Aranda, Remedios Martin
Abstract—Salt sensitivity of blood pressure is associated with an elevated risk of developing hypertension (HTN) and is
an independent risk factor for cardiovascular disease. The prevalence of HTN increases after menopause. The aim of
this study was to investigate prospectively whether the loss of ovarian hormones increases the occurrence of salt
sensitivity among healthy premenopausal women. We enrolled 40 normotensive, nondiabetic women (age 47.23.5),
undergoing hysterectomy–oophorectomy for nonneoplastic processes and not on hormone replacement, to determine the
effect of changes in sodium intake on blood pressure the day before and subsequently 4 months after surgical
menopause. Salt loading was achieved using a 2-L normal saline infusion and salt depletion produced by 40 mg of
intravenous furosemide. A decrease 10 mm Hg in systolic blood pressure between salt loading and salt depletion was
used to define salt sensitivity. Before and after menopause, salt-sensitive women exhibited higher waist/hip and
waist/thigh ratios (P0.01). Although all of the women remained normotensive, the prevalence of salt sensitivity was
significantly higher after surgical menopause (21 women; 52.5%) than before (9 women; 22.5%; P0.01), because 12
(38.7%) salt-resistant women developed salt sensitivity after menopause. In summary, we demonstrated that the
prevalence of salt sensitivity doubled as early as 4 months after surgical menopause, without an associated increase in
blood pressure. Epidemiological studies indicate that development of HTN may not occur until 5 to 10 years after
menopause. The loss of ovarian hormones may unmask a population of women prone to salt sensitivity who, with aging,
would be at higher risk for the subsequent development of HTN and cardiovascular disease. (Hypertension. 2006;
47:1168-1174.)
Key Words: risk factors  hormones  gender  cardiovascular diseases
Hypertension (HTN) is a major risk factor for cardiovas-cular disease (CVD), which is the leading cause of
morbidity and mortality in postmenopausal women.1,2 After
menopause, the sharp increase in the prevalence of HTN to
levels that equal or surpass that of men suggests that ovarian
hormones participate in the protection afforded to premeno-
pausal women.1,3–7 However, not all postmenopausal women
develop HTN and CVD; therefore, identifying those women
at risk is of critical importance.
Acute blood pressure elevation with increasing salt intake
(salt sensitivity [SS]) has been reported in certain segments
of the population, particularly among those with renal dis-
ease, diabetes, obesity, HTN, and older age.8,9 Studies by
Weinberger et al10 conducted in mixed groups of subjects
revealed that 26% of normotensive subjects and 51% of
hypertensive subjects could be reproducibly classified as SS
and that SS normotensive subjects are at an increased risk for
subsequent age-related HTN.11 Importantly, SS is an indepen-
dent risk factor for increased cardiovascular morbidity and
mortality in normotensive and hypertensive individuals.12,13
Postmenopausal women have been shown to be more SS
than premenopausal women.14,15 A study conducted in post-
menopausal women showed that SS correlated inversely with
levels of circulating ovarian hormones,16 suggesting that
decreases in ovarian hormone levels and increased sensitivity
to dietary sodium may be important factors in the genesis of
postmenopausal HTN. It has been reported that, compared
with premenopausal women, the pressure–natriuresis curve of
postmenopausal women is significantly shifted to the right.15
This indicates that blood pressure becomes SS after the
menopause, as first suggested by Weinberger et al.10 How-
ever, whether this increase in SS that develops after the
menopause is because of aging only or because of the loss of
ovarian hormones remains to be determined. The World
Health Organization Cardiovascular Diseases and Alimentary
Comparison Study found that there was a strong sodium–
blood pressure association, independent of age, in postmeno-
pausal women.17 They suggested 2 possible explanations.
One is that women who have increased SS after menopause
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may have had SS before menopause. The other is that
hormonal changes that occur immediately after menopause
may lead directly or indirectly, to some extent, to an increase
in SS. The purpose of the present study was to investigate
prospectively the prevalence rate of SS among a group of
healthy, normotensive, premenopausal women scheduled to
undergo hysterectomy and oophorectomy for nonneoplastic
processes to determine whether the loss of ovarian hormones
after surgical menopause increases SS.
Methods
Selection of Patients
Fifty women with preserved ovarian function scheduled to undergo
hysterectomy and ovariectomy for nonneoplastic gynecological
problems were initially considered eligible for the study. The
patients were selected from a group of 265 women who under-
went a preoperative examination at the Surgical Department of the
Hospital Materno Infantil of Malaga. To select the patients, the
women were asked to answer a self-administered questionnaire
concerning their gynecological history; personal history of CVDs,
diabetes mellitus, or other endocrine diseases; and previous use of
hormone therapy or nonsteroidal antiinflammatory drugs. After
completion of the questionnaire and a personal interview, women
45 years of age (except if they required ovariectomy) and 52
years of age; women with arterial HTN, diabetes mellitus, and other
cardiovascular and endocrine diseases; and women with a body mass
index (BMI) 32 were excluded from the study. Patients with
gynecological cancers were also excluded from the study. None of
the women were tobacco smokers. From the initial group of 50
women considered eligible for the study, 7 were subsequently
excluded because they underwent hysterectomy without ovariec-
tomy, and 3 refused to participate in the study after the surgery.
Therefore, the final study population consisted of 40 normotensive,
nondiabetic women with a mean age of 47 years (range, 43 to 52
years).
Study Design
The Ethics Committee of the Hospital Materno Infantil of Malaga
approved the research. All of the patients gave informed consent.
The procedures followed were in accordance with institutional
guidelines. To determine the effect of loss of ovarian hormones
on the development of SS, the patients underwent an acute
salt-loading and an acute salt-depletion protocol the day before
and subsequently 4 months after surgical menopause (hysterec-
tomy and oophorectomy). The patients were placed on a diet
containing 120 mmol/day of sodium chloride for 1 week before
being admitted for the acute study protocol. The patients were
admitted the day before the acute study protocol, and body
weight, height, BMI (weight in kg/height in m2), waist, hip, and
thigh circumferences; blood pressure; and heart rate were rec-
orded. Blood samples for hemoglobin, hematocrit, glucose, insu-
lin, triglycerides, high-density lipoprotein (HDL) cholesterol,
low-density lipoprotein (LDL) cholesterol, total cholesterol, apo-
lipoprotein B, uric acid, and creatinine were obtained after 12
hours of fasting. We obtained 24-hour urine collections for
sodium at baseline and after the administration of furosemide.
Urinary albumin excretion (mg/24 hours) was also measured from
the 24-hour collection obtained at baseline. Salt loading was
achieved with 2 L of normal saline infused over 3 hours. After the
salt loading, body weight and blood pressure measurements were
recorded, and salt depletion was produced by 40 mg of IV
furosemide. Body weight was determined using the same scale
(Atlantida, Sayol) at baseline and after the acute volume expan-
sion and depletion phases. Blood pressure monitoring was per-
formed with an ambulatory, automated, noninvasive oscillometric
device (SpaceLabs 90207, SpaceLabs, Inc). The average of 3
consecutive readings obtained at baseline, after the completion
of the saline infusion, and 3 hours after the administration of
intravenous furosemide were used to classify the patients into the
SS and salt-resistant groups. The cutoff used to define SS was a
decrease 10 mm Hg in systolic blood pressure between salt
loading and salt depletion. Our acute protocol has not been
compared with the established technique of Weinberger et al.10
Although the study time was shorter, we expect that this would,
if anything, underestimate the number of patients defined as SS.
We hypothesized that, in those patients with SS of blood pressure,
an acute volume expansion followed by acute depletion would
result in the same altered hemodynamic response regardless of the
time period during which it is achieved.
Statistical Analysis
Values are expressed as meanSD. Unpaired or paired Student t test
or 1-way ANOVA with Bonferroni posttest for multiple compari-
sons, when appropriate, was used to compare the different parame-
ters obtained between SS and salt-resistant women before and after
surgical menopause. Differences in proportions were tested by 2
statistics. P0.05 was used to reject the null hypothesis.
Results
Patient Characteristics Before Surgical Menopause
Table 1 shows the clinical characteristics and biochemical
data of the 40 premenopausal women scheduled for hys-
terectomy and oophorectomy who were included in the
study. No differences were observed in terms of age, BMI,
base-
line systolic and diastolic blood pressures, serum creati-
nine, hemoglobin, and hematocrit between premenopausal
women classified as SS versus salt resistant. Regarding the








Age, y 48.53.5 473.8 NS
Weight, kg 68.96.5 68.211.3 NS
BMI, kg/m2 28.41.8 27.94.1 NS
WC, cm 88.09.1 85.67.7 NS
Waist/hip ratio 0.850.05 0.820.04 0.001
Waist/thigh ratio 1.580.14 1.500.13 0.005
SBP, mm Hg 12914 12714 NS
DBP, mm Hg 769 798 NS
Serum biochemistry
Hemoglobin, g/L 12.31.2 12.71.0 NS
Hematocrit, % 37.02.6 37.52.3 NS
Glucose, mmol/L 5.820.47 5.410.95 NS
Insulin, mIU/mL 12.16.0 9.98.7 NS
Triglycerides, mmol/L 1.701.15 0.990.36 NS
Total cholesterol 5.440.67 5.380.93 NS
HDL, mmol/L 1.220.39 1.320.37 NS
LDL, mmol/L 3.670.85 3.510.88 NS
Uric acid, mol/L 26638 21852 NS
Creatinine, mmol/L 80.413.3 82.211.5 NS
Urine albumin, mg/day 20.221.9 4.58 0.08
Values are presented as meanSD. WC indicates waist circumference; SBP,
systolic blood pressure; DBP, diastolic blood pressure; NS, not significant.
*P for SS vs salt resistant is from unpaired t tests between the 2 groups.
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metabolic variables measured, no significant differences
were noted in waist circumference; fasting insulin; glu-
cose; uric acid; triglycerides; and total, HDL, and LDL
cholesterols. In contrast, waist/hip and waist/thigh ratios
were significantly higher in those classified as SS as
compared with salt resistant. Women classified as SS
exhibited a higher 24-hour urinary albumin excretion rate
that approached but did not reach statistical significance
(P0.08).
Patient Characteristics 4 Months After
Surgical Menopause
The clinical characteristics and biochemical data of the
patients 4 months after surgical menopause are shown on
Table 2. As noted before menopause, waist/hip and waist/
thigh ratios were significantly greater, and 24-hour urinary
albumin excretion rate was higher, although of borderline
significance (P0.06), in postmenopausal women classified
as SS versus salt resistant, whereas BMI; waist circumfer-
ence; systolic and diastolic blood pressures; fasting glucose;
triglycerides; and total, HDL, and LDL cholesterol were not
different between the groups. Of note, all of the women
remained normotensive 4 months after hysterectomy and
oophorectomy.
There were no statistically significant differences in BMI,
waist/hip and waist/thigh ratios, or insulin and uric acid levels
before as compared with 4 months after surgical menopause
among the SS women who remained SS, the salt resistant
who became SS, or the salt resistant who remained salt
resistant, according to our classification (Table 3). There was
a nonsignificant increase in insulin levels after surgical
menopause among the SS women who remained SS and
among the salt-resistant women who became SS, whereas
there was no change in insulin levels among those who
remained salt resistant after menopause. Similarly, we found
a nonsignificant increase in uric acid levels after menopause
among the women who became SS. The difference in insulin
and uric acid levels became statistically significant when the
postmenopausal SS group was compared with the postmeno-
pausal salt-resistant group (Table 2). Of note, the premeno-
pausal salt-resistant women who developed SS within 4
months after surgical menopause manifested waist/hip and
waist/thigh ratios that were similar to those of the SS women
who remained SS but significantly higher than those of the
salt-resistant women who remained salt resistant after surgi-
cal menopause (Table 3).
Prevalence of SS Before and 4 Months After
Surgical Menopause
The baseline blood pressures and body weights and the blood
pressure and body weight responses to salt loading and salt
depletion before and 4 months after hysterectomy and oopho-








Age, y 47.93.7 46.73.7 NS
Weight, kg 71.010.7 66.911 NS
BMI, kg/m2 29.23.9 27.24.1 NS
WC, cm 88.28.2 83.57.9 NS
Waist/hip ratio 0.870.06 0.790.03 0.001
Waist/thigh ratio 1.600.12 1.450.13 0.001
SBP, mm Hg 12818 12717 NS
DBP, mm Hg 799 7512 NS
Serum biochemistry
Hemoglobin, g/L 12.71.2 13.21.2 NS
Hematocrit, % 38.73.5 40.03.6 NS
Glucose, mmol/L 5.480.75 5.280.66 NS
Insulin, mIU/mL 15.36.6 10.03.2 0.002
Triglycerides, mmol/L 1.340.94 1.030.35 NS
Total cholesterol 5.490.88 5.280.88 NS
HDL, mmol/L 1.250.31 1.410.44 NS
LDL, mmol/L 3.610.86 3.330.86 NS
Uric acid, mol/L 25659 21750 0.02
Creatinine, mmol/L 74.316.8 69.014.1 NS
Urine albumin, mg/day 14.420.3 5.754.7 0.06
Values are presented as meanSD. WC indicates waist circumference; SBP,
systolic blood pressure; DBP, diastolic blood pressure; NS, not significant.
*P for SS vs salt resistant is from unpaired t tests between the 2 groups.









Premenopausal Postmenopausal Premenopausal Postmenopausal Premenopausal Postmenopausal
Characteristics
BMI, kg/m2 28.41.8 29.04.0 28.54.0 29.43.9 27.74.9 27.24.1
Waist/hip 0.850.05* 0.860.07† 0.880.07* 0.870.05† 0.790.03 0.790.03
Waist/thigh 1.580.14* 1.590.11† 1.600.12* 1.600.13† 1.430.14 1.450.13
Biochemistry
Insulin, mIU/mL 12.16.0 15.66.5 9.87.8 15.07.5 9.96.3 103.2
Uric acid, mol/L 26638 26058 22050 25359 21654 21750
Values are expressed as meanSD. Biochemical data obtained from serum.
*P0.05 vs premenopausal salt resistant; †P0.05 vs postmenopausal salt resistant.
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rectomy are shown in Tables 4 and 5. Before menopause,
systolic and diastolic blood pressures after salt loading were
higher (albeit not significantly) in women classified as SS
versus salt resistant, whereas systolic and diastolic blood
pressures after salt depletion were similar (Table 4). The fall
in systolic (and diastolic) blood pressure after salt depletion
was significantly greater in the SS than in the salt-resistant
premenopausal women. The SS group manifested a greater
weight gain and, thus, a greater weight loss in response to salt
loading and salt depletion, respectively, as compared with the
salt-resistant group. However, both groups returned to their
baseline weight after salt depletion. Sodium excretion
(mmol/24 hours) at baseline was not significantly different
between the 2 groups (148.24.6 versus 168.316.8,
Na mmol/24 hours, SS versus salt resistant; P0.07).
However, after diuretic administration, sodium excretion was
significantly higher in the salt-resistant group (182.27.5
versus 240.119.4, Na mmol/24 hours, SS versus salt
resistant; P0.001).
After surgical menopause, systolic and diastolic blood
pressures after salt loading were significantly higher in
women classified as SS versus salt resistant, whereas systolic
and diastolic blood pressures after salt depletion were similar
(Table 5).10,18 As expected, the fall in systolic (and diastolic)
blood pressure after salt depletion was significantly greater in
the SS than in the salt-resistant postmenopausal women. As
noted during the premenopausal period, the change in body
weight from salt loaded to salt depleted was slightly, but
significantly, greater in the SS postmenopausal women but
returned to baseline in both groups, as did the blood pres-
sures. Sodium excretion at baseline was slightly but signifi-
cantly greater in the SS group (183.541.2 versus
160.915.3, Na mmol/24 hours, SS versus salt resistant;
P0.02), whereas sodium excretion after diuretic adminis-
tration was greater in the salt-resistant group (233.413.9
versus 279.019.8, Na mmol/24 hours, SS versus salt
resistant; P0.001). The greater urinary sodium excretion in
response to the diuretic exhibited by the salt-resistant groups
TABLE 4. Blood Pressure and Body Weight Responses to Salt Loading and Depletion Before
Surgical Menopause
Variable Baseline Salt-Loaded Period Salt-Depleted Period  Between Periods
Systolic blood pressure
SS 12914 13815 12516 12.21.8
Salt resistant 12714 12716 11917 7.81.7
P for sensitive vs resistant* NS NS NS 0.001
Diastolic blood pressure
SS 769 9010 809 10.80.2
Salt resistant 798 808 749 5.90.9
P for sensitive vs resistant* NS NS NS 0.001
Body weight
SS 68.96.5 706 697 1.40.2
Salt resistant 68.211.3 6911 6811 0.90.1
P for sensitive vs resistant* NS NS NS 0.001
Values are presented as meanSD. NS indicates not significant.
*P for SS (n9) vs salt-resistant (n31) is from unpaired t tests between the 2 groups.
TABLE 5. Blood Pressure and Body Weight Responses to Salt Loading and Depletion After
Surgical Menopause
Variable Baseline Salt-Loaded Period Salt-Depleted Period  Between Periods
Systolic blood pressure
SS 12818 14620 12914 16.25.8
Salt resistant 12717 13214 12318 9.04.1
P for sensitive vs resistant NS 0.01 NS 0.001
Diastolic blood pressure
SS 799 928 799 12.81.3
Salt resistant 7512 8011 7510 4.90.3
P for sensitive vs resistant NS 0.001 NS 0.001
Body weight
SS 7110.7 7311 7111 1.70.1
Salt resistant 66.911 6811 6711 1.10.2
P for sensitive vs resistant NS NS NS 0.001
Values are presented as meanSD. NS indicates not significant.
*P for SS (n21) vs salt resistant (n19) is from unpaired t tests between the 2 groups.
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was reflected in the relatively greater change in blood
pressure after the diuretic than after sodium loading (Tables 4
and 5). The lesser sodium excretion produced by the diuretic
in the SS groups, both in the premenopausal and postmeno-
pausal states, may reflect an enhanced sodium conservation
by SS women.18
Based on our definition used to classify patients as SS (a
decrease 10 mm Hg in systolic blood pressure from the
salt-loaded to the salt-depleted phase, as described in the
Methods section), the prevalence of SS was significantly
higher after surgical menopause (21 women; 52.5%) than
before (9 women; 22.5%; P0.01; Figure), because 12
(38.7%) salt-resistant women developed SS after menopause.
Discussion
The major finding of this study is that the loss of ovarian
hormones after surgical menopause, independent of aging,
was associated with the development of SS in a substantive
number of previously salt-resistant women, as determined by
our acute protocol of salt loading and salt depletion. Indeed,
the number of women classified as SS was significantly
greater 4 months after surgical menopause. Our findings are
novel given that, to our knowledge, no previous study
examined in a longitudinal fashion the link between ovarian
hormones and the blood pressure response to salt loading in
humans. The World Health Organization Cardiovascular
Diseases and Alimentary Comparison Study suggested that
one of the mechanisms by which the menopause exerts its
effects on risk of CVD is a tendency for a strong sodium-
blood pressure association to develop, and our findings
support that notion. Thus, after menopause, the loss of the
ovarian hormones may unmask a population of women
predisposed to SS and HTN that would be at higher risk for
cardiovascular morbidity and mortality. The fact that this
occurs in young women not affected by other established
cardiovascular risk factors, which could confound our inter-
pretation, provides support for the role of estrogen in modu-
lating a potential important component in the pathogenesis of
postmenopausal HTN.
The present observations may have important implications
for CVD. SS hypertensive patients have a higher incidence of
left ventricular hypertrophy,19,20 endothelial dysfunction,21
hyperlipidemia,22,23 and microalbuminuria22–24 compared
with salt-resistant hypertensive patients. In addition, an asso-
ciation between insulin resistance and SS in nondiabetic, nono-
bese, essential hypertensive subjects has been reported.22,25
Associations between high normal urinary albumin excretion
and SS and between insulin resistance and SS have also been
found in young, healthy, normotensive subjects.24,26,27 Together,
these findings indicate that SS patients display a cluster of
cardiovascular risk factors and, thus, highlight the important link
between SS and CVD.28
In the present study, we found that the women classified as
SS, both before and after surgical menopause, exhibited
greater urinary albumin excretion than their salt-resistant
counterparts, although the differences did not reach statistical
significance. Low levels of urinary albumin excretion, well
below the current microalbuminuria threshold, have been shown
in recent studies to be associated with increased risk of coronary
heart disease and death independent of age, sex, renal function,
diabetes mellitus, HTN, and plasma lipids.29–31
Interestingly, we also found that, as compared with the
respective salt-resistant women, premenopausal and post-
menopausal SS women had significantly higher waist/hip and
waist/thigh ratios, which are estimations of the proportion of
abdominal or upper-body fat. In addition, postmenopausal SS
women exhibited significantly higher fasting insulin and uric
acid levels. To the extent that abdominal body fat and insulin
and uric acid levels have been proposed to constitute markers
of cardiovascular risk, the present study provides further
support for the linkage between SS and CVD.32–34
In our study population of women, blood pressure did not
rise after surgical menopause. An increment in visceral
adipose tissue deposition and worsening insulin-stimulated
glucose disposal has been observed during the menopause
transition.35,36 We did not observe differences in any of the
measured parameters before as compared with 4 months after
surgical menopause among the SS women who remained SS,
the salt resistant who became SS, or the salt resistant who
remained salt resistant (Table 3). These findings suggest that,
although salt-resistant women developed SS within 4 months
after surgical menopause, elevation of blood pressure and
changes in metabolic profile do not occur within this time
frame. In fact, the premenopausal women with SS and those
with salt resistance who developed SS after menopause
exhibited higher waist/hip and waist/thigh ratios as compared
with those who remained salt resistant after menopause.
These data indicate that, among those with increased abdom-
inal adiposity, loss of ovarian hormones may promote the
development of SS.
There is evidence that metabolic syndrome/insulin resis-
tance increases with aging and is associated with increased
risk of developing CVD.32,33 Epidemiological studies indicate
that development of HTN and CVD may not occur until 5 to
10 years after menopause.37,38 Therefore, we surmise that
the loss of ovarian hormones may unmask a population of
women predisposed to SS that, with aging and its associated
loss of vascular compliance, would subsequently be at higher
risk for the development of HTN and CVD.
Number of study participants with SS () and salt resistance
(SR, f) just before (premenopausal) and 4 months after hyster-
ectomy and ovariectomy (postmenopausal). *Significant increase
in number of women with SS after surgical menopause
(P0.01).
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The present findings suggest a mechanism whereby loss of
estrogen may foster postmenopausal HTN.4,5 We and others
have demonstrated previously that ovariectomized SS rats
develop HTN while receiving a “normal” salt (0.5% NaCl)
diet, suggesting that the loss of ovarian hormones lowers the
threshold for the hypertensinogenic effect of salt.39,40 The
development of SS postovariectomy HTN was linked to an
upregulation of renal angiotensin type 1 receptor expres-
sion39,40 and a reduction in renal medullary endothelial nitric
oxide synthase activity41 and was prevented by estrogen
replacement,39,40 angiotensin type 1 receptor antagonism,39,40
or very low salt diet (0.1% NaCl).39 These findings support an
important role of angiotensin II and NO on sodium homeosta-
sis and point to the loss of estrogen modulation of the
renin–angiotensin and NO systems as pathogenic mecha-
nisms in postmenopausal HTN and as additional targets for
reducing the risks of CVD in postmenopausal women.
The main limitation of our study is the technique used to
classify the patients. The protocol time was shorter than
the acute protocol established by Weinberger et al.10 We
surmise that, in those patients with an altered hemodynamic
response to salt loading (ie, SS), an acute volume expansion
with saline followed by acute depletion with furosemide
would result in the same pathophysiological response regard-
less of the time period during which it is achieved. Our acute
protocol may, if anything, underestimate the number of
patients defined as SS.
Perspectives
The report from the National Health and Nutrition Examina-
tion Survey revealed that women are among those with the
highest rates of HTN and the lowest rates of control,
especially after age 60, highlighting the need for interventions
that would target prevention in this group.7 Our present
results may provide new insights to explain why the incidence
of HTN and CVD increases in postmenopausal women3 and
provide the basis for the design of larger, observational as well
as interventional studies in this population.
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